Early use of powerful CF drugs may boost growth in young children
Disease control
Recruiting now
This study looks at how highly effective CFTR modulators—medicines like Kalydeco and Trikafta—affect growth and health in infants and young children with cystic fibrosis. Researchers will track changes in weight and height over time in children under 10 years old. The goal is to …
Sponsor: Sonya Heltshe • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC